Home › Compare › CATPF vs JNJ

CATPF vs JNJ: Dividend Comparison 2026

CATPF yields 11111.11% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CATPF wins by $155845322245618304.00M in total portfolio value
10 years
CATPF
CATPF
● Live price
11111.11%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$155845322245618304.00M
Annual income
$153,134,179,268,263,440,000,000.00
Full CATPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CATPF vs JNJ

📍 CATPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCATPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CATPF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CATPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CATPF
Annual income on $10K today (after 15% tax)
$944,444.44/yr
After 10yr DRIP, annual income (after tax)
$130,164,052,378,023,920,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CATPF beats the other by $130,164,052,378,023,920,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CATPF + JNJ for your $10,000?

CATPF: 50%JNJ: 50%
100% JNJ50/50100% CATPF
Portfolio after 10yr
$77922661122809152.00M
Annual income
$76,567,089,634,131,720,000,000.00/yr
Blended yield
98.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CATPF
No analyst data
Altman Z
-1.4
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CATPF buys
0
JNJ buys
0
No recent congressional trades found for CATPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCATPFJNJ
Forward yield11111.11% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$155845322245618304.00M ✓$20.0K
Annual income after 10y$153,134,179,268,263,440,000,000.00 ✓$827.78
Total dividends collected$155665220770885760.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CATPF vs JNJ ($10,000, DRIP)

YearCATPF PortfolioCATPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,121,811$1,111,111.11$10,676$355.77+$1.11M → CATPF
2$117,691,627$116,491,288.80$11,407$389.39+$117.68M → CATPF
3$11,547,755,012$11,421,824,971.17$12,198$426.53+$11547.74M → CATPF
4$1,059,734,753,299$1,047,378,655,436.53$13,056$467.62+$1059734.74M → CATPF
5$90,963,535,000,723$89,829,618,814,692.62$13,987$513.12+$90963534.99M → CATPF
6$7,303,524,681,616,793$7,206,193,699,166,020.00$14,998$563.56+$7303524681.60M → CATPF
7$548,553,313,414,587,650$540,738,542,005,257,700.00$16,098$619.52+$548553313414.57M → CATPF
8$38,543,778,083,006,005,000$37,956,826,037,652,400,000.00$17,295$681.69+$38543778083005.99M → CATPF
9$2,533,778,483,509,246,600,000$2,492,536,640,960,430,300,000.00$18,599$750.82+$2533778483509246.50M → CATPF
10$155,845,322,245,618,300,000,000$153,134,179,268,263,440,000,000.00$20,022$827.78+$155845322245618304.00M → CATPF

CATPF vs JNJ: Complete Analysis 2026

CATPF — Stock

Giyani Metals Corp. engages in the exploration, evaluation, and development of manganese mining projects in Botswana, Africa. The company's flagship project is the K.Hill project covering a total license area of 2,588 square kilometers located in southeastern Botswana. It also holds interests in Otse and Lobatse manganese prospects. The company was formerly known as Giyani Gold Corp. and changed its name to Giyani Metals Corp. in July 2017. Giyani Metals Corp. was incorporated in 2007 and is based in Vancouver, Canada.

Full CATPF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CATPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CATPF vs SCHDCATPF vs JEPICATPF vs OCATPF vs KOCATPF vs MAINCATPF vs ABBVCATPF vs MRKCATPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.